Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response
Cancers · 27.11.2023 · 15 (23) · 5597
DOI: 10.3390/cancers15235597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 27.11.2023. Verfasst von Anne-Sophie Becker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Rostock University Medical Center, 18057 Rostock, Germany. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin Rostock, University of Medicine Rostock.
Abstract (Originalsprache)
The 5-year survival rate for head and neck squamous cell carcinoma (HNSCC) is approximately 65%. In addition to radio-chemotherapy, immunotherapy is an approach in the treatment of advanced HNSCC. A better understanding of the immune context would allow personalized treatment by identifying patients who are best suited for different treatment options. In our discovery cohort, we evaluated the expression profiles of CMTM6, PD-L1, CTLA-4, and FOXP3 in 177 HNSCCs from Caucasian patients of all tumor stages and different treatment regimens, correlating marker expression in tumor and immune cells with outcomes. Patients with CMTM6high-expressing tumors had a longer overall survival regardless of treatment. This prognostic benefit of CMTM6 in HNSCC was validated in an independent cohort. Focusing on the in the discovery cohort (n = 177), a good predictive effect of CMTM6high expression was seen in patients receiving radiotherapy (p = 0.07; log rank), but not in others. CMTM6 correlated with PD-L1, CTLA-4 and FOXP3 positivity, with patients possessing CMTM6high/FOXP3high tumors showing the longest survival regardless of treatment. In chemotherapy-treated patients, PD-L1 positivity was associated with longer progression-free survival (p < 0.05). In the 27 patients who received immunotherapy, gene expression analysis revealed lower levels of CTLA-4 and FOXP3 with either partial or complete response to this treatment, while no effect was observed for CMTM6 or PD-L1. The combination of these immunomodulatory markers seems to be an interesting prognostic and predictive signature for HNSCC patients with the ability to optimize individualized treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pathology, Rostock University Medical Center, 18057 Rostock, Germany.
- Department of Otorhinolaryngology, Head and Neck Surgery "Otto Koerner", Rostock University Medical Center, 18057 Rostock, Germany.
- Department of Internal Medicine B, Cardiology, University Medicine Greifswald, 17475 Greifswald, Germany.
- Institute of Pathology, University of Luebeck, University Hospital Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany.
- Department of Oto-Rhino-Laryngology & Head and Neck Surgery, University of Lubeck, University Hospital Schleswig-Holstein, Campus Luebeck, 23538 Luebeck, Germany.
- Department of Internal Medicine, Medical Clinic III-Hematology, Oncology, Palliative Medicine, Rostock University Medical Center, 18057 Rostock, Germany.
ORCID-Profile: Björn Schneider, Daniel Strüder, Caterina Redwanz, Claudia Maletzki
Förderung
- Universitätsmedizin Rostock
- University of Medicine Rostock
Zitieren
APA
Becker, A. S., Kluge, C., Schofeld, C., Zimpfer, A. H., Schneider, B., Strüder, D., Redwanz, C., Ribbat-Idel, J., Idel, C., & Maletzki, C. (2023). Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers, 15(23), 5597. https://doi.org/10.3390/cancers15235597
Vancouver
Becker AS, Kluge C, Schofeld C, Zimpfer AH, Schneider B, Strüder D, et al. Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response. Cancers. 2023;15(23):5597. doi:10.3390/cancers15235597
BibTeX
@article{Becker2023,
author = {Becker, Anne-Sophie and Kluge, Cornelius and Schofeld, Carsten and Zimpfer, Annette Helene and Schneider, Björn and Strüder, Daniel and Redwanz, Caterina and Ribbat-Idel, Julika and Idel, Christian and Maletzki, Claudia},
title = {Identifying Predictive Biomarkers for Head and Neck Squamous Cell Carcinoma Response},
journal = {Cancers},
year = {2023},
volume = {15},
number = {23},
pages = {5597},
doi = {10.3390/cancers15235597}
}
EUVIMED